Disability

Enlyte Celebrates National Adjuster Day by Launching Streamlined DecisionPoint Interface

Revised system is designed to empower adjuster decision-making and increase productivity SAN DIEGO, Aug. 16, 2024 /PRNewswire/ -- Adjusters are often…

3 months ago

Remote access, real impacts: Assessing telehealth attitudes and usage in Northwest Colorado

New report identifies benefits and concerns regarding telehealth, provides recommendations for improving perceptions  DENVER, Aug. 14, 2024 /PRNewswire/ -- The Office…

3 months ago

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

• ONP-002 stability eliminates need for cumbersome cold storage• No FDA-approved pharmaceutical treatment available for concussion SARASOTA, Fla., Aug. 14,…

3 months ago

Uplifting Military and Disability Communities: The N2 Company Launches Salute & Uniquely You Magazines

IRVING, Texas, Aug. 13, 2024 /PRNewswire/ -- The N2 Company (N2) recently launched two groundbreaking monthly magazines, Salute and Uniquely You,…

3 months ago

Theralase(R) Release’s 2Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / August 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

3 months ago

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

The potential addressable market opportunity for ONP-002 includes an estimated 69 million concussions globallySARASOTA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE)…

4 months ago

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3…

4 months ago

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028

WAKIX® (pitolisant) Net Revenue of $172.8 Million for Second Quarter 2024; ~29% Growth Year-over-Year Next Generation Pitolisant High-Dose (HD) Program…

4 months ago

Houston Medical Waste Disposal Company Tackles Piercing Surge in Needlestick Injuries With Essential Guide

The CDC has reported an estimated 385,000 incidents of needlestick and sharps-related injuries among healthcare workers annually in the U.S.HOUSTON,…

4 months ago

AFB Names 2024 Migel Medal Honorees

WASHINGTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The American Foundation for the Blind (AFB) has announced that Kim Charlson and…

4 months ago